The University of Chicago Header Logo

Olufunmilayo Olopade

Concepts (1157)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
292
2023
2904
23.410
Why?
Genes, BRCA1
86
2023
192
10.400
Why?
Genes, BRCA2
72
2023
160
8.670
Why?
Genetic Predisposition to Disease
140
2023
2272
8.410
Why?
BRCA1 Protein
61
2023
200
8.300
Why?
BRCA2 Protein
52
2023
158
7.110
Why?
Genetic Testing
52
2023
535
5.820
Why?
Mutation
114
2023
3977
5.400
Why?
Ovarian Neoplasms
56
2023
744
5.330
Why?
Triple Negative Breast Neoplasms
15
2023
137
5.250
Why?
Germ-Line Mutation
42
2022
330
4.680
Why?
Female
374
2023
44562
3.950
Why?
Nigeria
40
2023
152
3.860
Why?
Humans
457
2023
86650
3.190
Why?
Polymorphism, Single Nucleotide
73
2023
2357
2.980
Why?
Neoplasms
36
2023
2898
2.960
Why?
Middle Aged
206
2023
25027
2.790
Why?
Biomarkers, Tumor
30
2021
1464
2.620
Why?
Genomics
10
2020
720
2.520
Why?
Heterozygote
50
2020
366
2.450
Why?
Adult
191
2023
25648
2.380
Why?
Genetic Counseling
18
2023
100
2.210
Why?
Genome-Wide Association Study
39
2023
1621
2.160
Why?
Receptors, Estrogen
27
2022
384
2.090
Why?
Receptors, Progesterone
16
2018
167
2.060
Why?
Carcinoma, Ductal, Breast
10
2021
157
1.970
Why?
Receptor, ErbB-2
21
2023
224
1.900
Why?
Chromosomes, Human, Pair 9
21
2016
86
1.880
Why?
Health Status Disparities
6
2023
170
1.840
Why?
Aged
123
2023
18407
1.670
Why?
Gene Expression Regulation, Neoplastic
26
2021
1197
1.640
Why?
Risk Factors
82
2023
5416
1.610
Why?
Ovariectomy
18
2022
81
1.570
Why?
Case-Control Studies
54
2023
1809
1.520
Why?
Glucuronosyltransferase
9
2014
185
1.510
Why?
Risk Assessment
39
2021
2261
1.490
Why?
DNA Methylation
12
2018
630
1.470
Why?
Alleles
29
2021
1129
1.460
Why?
Estrogen Receptor alpha
10
2017
144
1.400
Why?
Breast
19
2023
288
1.380
Why?
Neoadjuvant Therapy
10
2023
318
1.350
Why?
Precision Medicine
6
2023
395
1.330
Why?
Promoter Regions, Genetic
16
2019
943
1.300
Why?
Breast Neoplasms, Male
9
2019
30
1.290
Why?
Mammography
15
2018
463
1.280
Why?
Early Detection of Cancer
8
2019
395
1.280
Why?
Colorectal Neoplasms
11
2019
938
1.270
Why?
Health Knowledge, Attitudes, Practice
6
2017
508
1.240
Why?
Health Services Accessibility
7
2021
394
1.230
Why?
Prognosis
45
2023
3681
1.230
Why?
Neoplasm Staging
26
2023
1938
1.160
Why?
Genotype
36
2023
1853
1.160
Why?
Tumor Suppressor Proteins
9
2020
279
1.160
Why?
Tamoxifen
7
2023
168
1.120
Why?
Magnetic Resonance Imaging
13
2020
3361
1.120
Why?
Body Height
5
2021
99
1.110
Why?
Neoplasms, Second Primary
11
2014
252
1.090
Why?
Mass Screening
7
2018
619
1.080
Why?
Up-Regulation
4
2018
717
1.070
Why?
Proto-Oncogene Proteins c-myc
6
2015
120
1.070
Why?
Gene Expression Profiling
17
2021
1387
1.060
Why?
Chromosome Deletion
13
2001
229
1.050
Why?
Chromosome Aberrations
9
2014
387
1.050
Why?
Aged, 80 and over
47
2023
6511
1.030
Why?
Neoplasm Proteins
10
2019
532
1.020
Why?
Paclitaxel
8
2019
460
0.980
Why?
Mastectomy
13
2023
243
0.970
Why?
Jews
6
2018
42
0.960
Why?
DNA Mutational Analysis
18
2021
526
0.960
Why?
United States
32
2023
6674
0.960
Why?
Genetic Services
3
2023
7
0.950
Why?
Carcinoma, Intraductal, Noninfiltrating
3
2022
113
0.940
Why?
Cell Line, Tumor
25
2021
2427
0.920
Why?
Medical Oncology
7
2021
360
0.910
Why?
Cohort Studies
31
2023
2763
0.880
Why?
Breast Feeding
3
2020
91
0.880
Why?
Ubiquitin-Protein Ligases
6
2020
165
0.880
Why?
Parity
5
2015
93
0.870
Why?
Antineoplastic Combined Chemotherapy Protocols
14
2020
2438
0.870
Why?
Neoplasms, Basal Cell
3
2018
9
0.870
Why?
Founder Effect
6
2018
104
0.860
Why?
Tumor Suppressor Protein p53
7
2022
381
0.860
Why?
Fallopian Tube Neoplasms
3
2019
35
0.850
Why?
Pancreatic Neoplasms
6
2019
645
0.850
Why?
Neoplasm Recurrence, Local
11
2023
1313
0.840
Why?
Epigenesis, Genetic
8
2018
481
0.830
Why?
Capacity Building
4
2020
10
0.830
Why?
Clonal Evolution
1
2021
15
0.820
Why?
Genetic Loci
12
2019
250
0.820
Why?
Exons
8
2016
452
0.810
Why?
Body Mass Index
9
2021
768
0.800
Why?
Healthcare Disparities
7
2023
372
0.780
Why?
Cross-Sectional Studies
9
2023
1618
0.780
Why?
Germ Cells
4
2023
126
0.780
Why?
Gene Deletion
10
2002
337
0.780
Why?
RNA, Long Noncoding
2
2021
110
0.770
Why?
Drug Resistance, Neoplasm
8
2019
592
0.760
Why?
Male
74
2023
40992
0.760
Why?
Risk
25
2022
674
0.760
Why?
Demography
2
2023
177
0.750
Why?
Genomic Instability
5
2021
79
0.750
Why?
Introns
5
2021
290
0.750
Why?
Preventive Health Services
2
2019
37
0.750
Why?
Health Personnel
2
2022
201
0.740
Why?
Medicine, African Traditional
1
2020
3
0.740
Why?
Radiation Oncology
2
2020
119
0.740
Why?
Alternative Splicing
5
2016
202
0.740
Why?
Peritoneal Neoplasms
3
2019
177
0.730
Why?
Biomedical Research
5
2019
376
0.730
Why?
Doxorubicin
9
2020
295
0.730
Why?
In Situ Hybridization, Fluorescence
17
2022
349
0.730
Why?
Pedigree
18
2018
966
0.720
Why?
Pharmacogenetics
2
2021
434
0.710
Why?
Antineoplastic Agents
8
2018
2360
0.700
Why?
Antimetabolites, Antineoplastic
5
2020
236
0.700
Why?
Genes, erbB-2
4
2009
24
0.690
Why?
CpG Islands
5
2016
152
0.690
Why?
Bromobenzenes
1
2019
2
0.690
Why?
Copper-transporting ATPases
1
2019
12
0.690
Why?
Molybdenum
1
2019
12
0.690
Why?
Checkpoint Kinase 2
2
2018
23
0.690
Why?
Benzothiazoles
1
2019
17
0.680
Why?
Neovascularization, Pathologic
3
2019
356
0.680
Why?
Transcription Factors
12
2017
1580
0.680
Why?
Tumor Microenvironment
4
2021
418
0.680
Why?
DNA-Binding Proteins
13
2016
1214
0.680
Why?
Clinical Trials as Topic
6
2020
1169
0.680
Why?
Fluorobenzenes
1
2019
33
0.670
Why?
Ataxia Telangiectasia Mutated Proteins
2
2018
52
0.670
Why?
Minority Groups
5
2018
137
0.670
Why?
beta Catenin
4
2015
255
0.670
Why?
Young Adult
29
2023
5976
0.670
Why?
Haplotypes
15
2019
642
0.660
Why?
Proportional Hazards Models
21
2021
860
0.660
Why?
Molecular Chaperones
1
2019
111
0.650
Why?
Physicians
4
2022
673
0.650
Why?
Genetic Variation
14
2021
1351
0.640
Why?
Polymorphism, Genetic
9
2012
819
0.640
Why?
Women, Working
1
2017
7
0.630
Why?
Carcinoma
3
2014
436
0.630
Why?
Medicaid
1
2020
217
0.610
Why?
Genome, Human
6
2020
756
0.610
Why?
Premenopause
6
2013
54
0.610
Why?
Brain Neoplasms
5
2016
763
0.600
Why?
Hereditary Breast and Ovarian Cancer Syndrome
2
2018
10
0.600
Why?
Molecular Epidemiology
2
2019
53
0.600
Why?
Circulating MicroRNA
1
2016
12
0.570
Why?
Antineoplastic Agents, Hormonal
4
2017
150
0.570
Why?
Odds Ratio
21
2022
679
0.560
Why?
Bibliometrics
1
2016
37
0.550
Why?
Fanconi Anemia Complementation Group F Protein
3
2019
6
0.550
Why?
Biological Products
1
2018
143
0.550
Why?
Socioeconomic Factors
7
2020
567
0.550
Why?
Disease-Free Survival
12
2023
1204
0.550
Why?
Chromosome Mapping
19
2019
1074
0.550
Why?
Genetic Association Studies
12
2019
294
0.550
Why?
Microsatellite Repeats
4
2016
145
0.540
Why?
Survival Analysis
19
2021
1540
0.540
Why?
Purine-Nucleoside Phosphorylase
11
2001
23
0.540
Why?
Body Weight
3
2021
458
0.540
Why?
Adenocarcinoma
6
2011
1169
0.540
Why?
Estrogen Receptor beta
2
2012
25
0.530
Why?
Cyclin-Dependent Kinase Inhibitor p16
10
2018
104
0.530
Why?
Retrospective Studies
28
2023
8476
0.530
Why?
Neoplasms, Glandular and Epithelial
4
2017
74
0.520
Why?
Genes, Tumor Suppressor
13
2016
157
0.510
Why?
Genetic Carrier Screening
8
2016
60
0.510
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2015
74
0.510
Why?
Transcriptome
5
2023
580
0.500
Why?
Chromosomes, Human, Pair 5
4
2008
109
0.500
Why?
MicroRNAs
6
2019
535
0.490
Why?
ErbB Receptors
5
2012
486
0.480
Why?
Nuclear Proteins
6
2017
705
0.480
Why?
Vascular Endothelial Growth Factor A
2
2013
411
0.460
Why?
Uganda
4
2023
34
0.460
Why?
Quinazolines
5
2015
220
0.460
Why?
Pathology
1
2013
30
0.460
Why?
Protein-Arginine N-Methyltransferases
1
2013
12
0.460
Why?
Computer-Assisted Instruction
1
2013
43
0.460
Why?
Leukemia
3
2014
320
0.450
Why?
Age Factors
19
2019
1849
0.450
Why?
Chromosome Disorders
4
2001
114
0.440
Why?
Gene Rearrangement
6
2010
170
0.440
Why?
Postmenopause
3
2013
98
0.440
Why?
Base Sequence
19
2016
2335
0.440
Why?
Chromosomes, Human, Pair 6
5
2019
125
0.440
Why?
Global Health
3
2015
193
0.440
Why?
Africa South of the Sahara
4
2023
21
0.440
Why?
Reproductive Physiological Phenomena
1
2012
4
0.440
Why?
Logistic Models
12
2017
1185
0.430
Why?
Proto-Oncogene Proteins
3
2011
645
0.430
Why?
Macrophages
2
2013
560
0.430
Why?
Adenocarcinoma, Mucinous
1
2012
48
0.430
Why?
Fanconi Anemia Complementation Group N Protein
3
2019
13
0.430
Why?
RNA, Messenger
11
2022
1988
0.430
Why?
Genes, myc
2
2011
39
0.430
Why?
MCF-7 Cells
7
2018
106
0.430
Why?
Epigenomics
1
2013
100
0.430
Why?
DNA, Neoplasm
7
2019
265
0.430
Why?
Adolescent
27
2023
8982
0.430
Why?
Lactation
1
2012
53
0.420
Why?
Waist-Hip Ratio
1
2012
18
0.420
Why?
Awareness
1
2013
93
0.420
Why?
Body Fat Distribution
1
2012
13
0.420
Why?
Deoxycytidine
1
2013
237
0.420
Why?
Delivery of Health Care
2
2015
426
0.420
Why?
Gene Expression Regulation, Enzymologic
1
2013
215
0.410
Why?
Surveys and Questionnaires
9
2020
2502
0.410
Why?
Receptors, Androgen
1
2012
113
0.410
Why?
Fluorouracil
2
2013
556
0.410
Why?
Ambulatory Care Facilities
1
2013
103
0.410
Why?
E-Box Elements
1
2011
5
0.400
Why?
Estrogen Antagonists
2
2011
48
0.400
Why?
Radiographic Image Interpretation, Computer-Assisted
5
2012
466
0.400
Why?
Cooking
3
2017
55
0.400
Why?
Chromosomes, Human, Pair 17
4
2019
110
0.390
Why?
Biopsy
7
2021
1163
0.390
Why?
Survival Rate
11
2023
1864
0.390
Why?
Head and Neck Neoplasms
6
2019
1052
0.390
Why?
Tumor Cells, Cultured
21
2006
1041
0.390
Why?
Cytochrome P-450 CYP2D6
1
2011
52
0.380
Why?
ras Proteins
1
2011
128
0.380
Why?
Prostatic Neoplasms
8
2019
1721
0.380
Why?
Proto-Oncogene Proteins B-raf
1
2011
138
0.380
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
4
2015
42
0.370
Why?
Fallopian Tubes
3
2017
41
0.370
Why?
Urinary Bladder Neoplasms
5
2001
383
0.370
Why?
Chicago
11
2021
1380
0.370
Why?
Gene Fusion
1
2010
38
0.370
Why?
Quantitative Trait Loci
8
2023
577
0.370
Why?
Interdisciplinary Communication
2
2012
130
0.370
Why?
Lung Neoplasms
10
2023
2262
0.370
Why?
Group Processes
1
2010
31
0.370
Why?
Gene Frequency
11
2016
677
0.370
Why?
Age of Onset
13
2018
310
0.370
Why?
Community-Institutional Relations
1
2010
29
0.370
Why?
Homozygote
7
2007
200
0.360
Why?
Cell Proliferation
9
2019
1596
0.360
Why?
Contrast Media
8
2020
1073
0.360
Why?
Prospective Studies
16
2022
4212
0.360
Why?
Molecular Sequence Data
16
2012
3035
0.350
Why?
Quality Improvement
1
2013
427
0.350
Why?
Family
7
2018
311
0.350
Why?
Sequence Deletion
7
2019
206
0.350
Why?
DNA Copy Number Variations
4
2022
171
0.350
Why?
Leukemia, Myeloid
3
2004
249
0.350
Why?
Endometrial Neoplasms
3
2022
193
0.350
Why?
Lymphoma, Non-Hodgkin
4
1998
261
0.340
Why?
Mice
19
2023
11439
0.340
Why?
Mendelian Randomization Analysis
2
2019
43
0.340
Why?
Truth Disclosure
3
2018
87
0.340
Why?
Risk Reduction Behavior
5
2014
98
0.330
Why?
Antibodies, Monoclonal, Humanized
3
2013
931
0.330
Why?
Complementary Therapies
2
2023
54
0.330
Why?
Colonic Neoplasms
3
2016
557
0.330
Why?
Trans-Activators
5
2021
430
0.330
Why?
Linkage Disequilibrium
9
2021
473
0.330
Why?
Information Storage and Retrieval
2
2008
120
0.330
Why?
Carrier Proteins
7
2016
675
0.330
Why?
Systems Integration
1
2008
35
0.330
Why?
Database Management Systems
1
2008
41
0.320
Why?
Aneuploidy
2
2005
55
0.320
Why?
Universities
3
2019
135
0.320
Why?
DNA Repair
6
2014
356
0.320
Why?
Image Processing, Computer-Assisted
6
2021
1204
0.320
Why?
Disclosure
4
2020
108
0.320
Why?
Immunohistochemistry
12
2022
1759
0.310
Why?
Allelic Imbalance
3
2013
20
0.300
Why?
Cell Cycle Proteins
5
2016
388
0.300
Why?
Patient Protection and Affordable Care Act
2
2020
66
0.300
Why?
Xenograft Model Antitumor Assays
6
2021
458
0.300
Why?
Gene Expression
7
2018
1286
0.300
Why?
TOR Serine-Threonine Kinases
2
2019
182
0.300
Why?
Bilirubin
1
2007
125
0.300
Why?
Capecitabine
2
2020
96
0.290
Why?
Multigene Family
6
2014
202
0.290
Why?
Computational Biology
3
2016
528
0.290
Why?
Chromosomes, Human, Pair 7
2
2000
79
0.290
Why?
Neoplasm Grading
4
2021
357
0.290
Why?
Signal Transduction
9
2018
3267
0.290
Why?
Binding Sites
7
2020
1104
0.280
Why?
Social Environment
1
2008
189
0.280
Why?
Schools, Medical
2
2019
123
0.280
Why?
Genetics, Population
4
2018
394
0.280
Why?
Pregnancy
10
2018
2901
0.280
Why?
Hospitals, Teaching
2
2018
116
0.280
Why?
Obesity
3
2013
964
0.280
Why?
Cell Cycle
2
2020
503
0.270
Why?
Quality of Health Care
3
2017
381
0.270
Why?
Prevalence
7
2021
1239
0.270
Why?
Interviews as Topic
4
2018
319
0.270
Why?
Menarche
2
2021
24
0.270
Why?
Phenotype
10
2019
2389
0.270
Why?
Developing Countries
2
2016
71
0.260
Why?
Multivariate Analysis
10
2017
999
0.260
Why?
Brazil
2
2022
69
0.260
Why?
High-Throughput Nucleotide Sequencing
4
2019
456
0.260
Why?
Glioma
5
1998
285
0.260
Why?
Depressive Disorder
1
2006
218
0.260
Why?
TNF-Related Apoptosis-Inducing Ligand
2
2023
25
0.260
Why?
Community Participation
2
2014
36
0.260
Why?
Polymerase Chain Reaction
10
2011
930
0.260
Why?
Kaplan-Meier Estimate
7
2023
861
0.250
Why?
Apoptosis
4
2019
1689
0.250
Why?
Air Pollution, Indoor
2
2017
63
0.250
Why?
Carcinoma, Squamous Cell
5
2015
1077
0.250
Why?
Multifactorial Inheritance
4
2022
159
0.250
Why?
RNA, Small Interfering
4
2015
547
0.250
Why?
Family Health
5
2011
162
0.250
Why?
Vulnerable Populations
2
2020
76
0.240
Why?
Weight Gain
2
2021
123
0.240
Why?
Breast Diseases
3
2018
97
0.240
Why?
Salpingostomy
1
2004
1
0.240
Why?
Data Collection
3
2023
372
0.240
Why?
Pseudogenes
3
2021
35
0.240
Why?
Whole Genome Sequencing
2
2021
76
0.240
Why?
Genetic Heterogeneity
2
2021
62
0.240
Why?
Copper
2
2019
71
0.240
Why?
Rosaniline Dyes
1
2023
9
0.240
Why?
Population Surveillance
4
2019
219
0.240
Why?
Databases, Genetic
4
2019
260
0.240
Why?
Sequence Analysis, DNA
7
2018
853
0.240
Why?
Animals
20
2023
26706
0.240
Why?
Cameroon
3
2023
14
0.230
Why?
GATA3 Transcription Factor
2
2021
48
0.230
Why?
Marital Status
1
2023
40
0.230
Why?
Epithelial-Mesenchymal Transition
5
2014
76
0.230
Why?
Marketing of Health Services
1
2003
15
0.230
Why?
Metformin
2
2016
128
0.230
Why?
Neoplasm, Residual
2
2023
162
0.230
Why?
DNA Mismatch Repair
2
2015
52
0.230
Why?
Cyclophosphamide
4
2020
299
0.230
Why?
Carcinoma, Lobular
3
2014
81
0.230
Why?
Yoga
1
2023
5
0.220
Why?
Meditation
1
2023
5
0.220
Why?
Loss of Heterozygosity
5
2016
85
0.220
Why?
Age Distribution
4
2013
204
0.220
Why?
Reverse Transcriptase Polymerase Chain Reaction
6
2013
881
0.220
Why?
Proto-Oncogene Proteins p21(ras)
2
2015
154
0.220
Why?
Chemotherapy, Adjuvant
5
2023
468
0.220
Why?
Metabolome
1
2023
47
0.220
Why?
Hematologic Neoplasms
1
2006
329
0.210
Why?
Hypoglycemic Agents
2
2016
378
0.210
Why?
Interferons
6
1995
133
0.210
Why?
Pharmacists
1
2022
32
0.210
Why?
Synaptophysin
1
2021
11
0.210
Why?
Mutation, Missense
2
2007
276
0.210
Why?
Physician's Role
2
2017
179
0.210
Why?
Disease Progression
8
2019
1534
0.210
Why?
Regulatory Sequences, Nucleic Acid
3
2017
148
0.210
Why?
Social Class
2
2016
128
0.210
Why?
Exome
2
2019
127
0.200
Why?
Public Health
2
2013
129
0.200
Why?
DNA Probes
5
1997
77
0.200
Why?
Genes, p16
1
2001
11
0.200
Why?
DNA Helicases
1
2022
82
0.200
Why?
Follow-Up Studies
8
2020
3639
0.200
Why?
Oligonucleotide Array Sequence Analysis
8
2009
691
0.200
Why?
Internationality
2
2019
69
0.200
Why?
Microfilament Proteins
2
2013
209
0.200
Why?
Hamartoma Syndrome, Multiple
1
2001
10
0.200
Why?
Protein-Tyrosine Kinases
2
2013
302
0.200
Why?
Antineoplastic Agents, Phytogenic
2
2019
276
0.190
Why?
Needs Assessment
1
2022
154
0.190
Why?
Receptor, Fibroblast Growth Factor, Type 2
3
2010
12
0.190
Why?
RNA-Binding Proteins
1
2003
251
0.190
Why?
Women's Health
2
2018
100
0.190
Why?
Myelodysplastic Syndromes
2
2012
346
0.190
Why?
Specimen Handling
1
2021
98
0.190
Why?
Parent-Child Relations
3
2012
77
0.190
Why?
Small Molecule Libraries
2
2019
61
0.190
Why?
Fourier Analysis
4
2014
125
0.190
Why?
Chromosomes, Artificial, Yeast
5
1995
37
0.190
Why?
Phosphoric Monoester Hydrolases
1
2001
51
0.190
Why?
Databases, Factual
6
2017
816
0.190
Why?
Telemedicine
1
2023
168
0.190
Why?
Tumor Escape
1
2021
49
0.190
Why?
Africa
4
2021
98
0.190
Why?
Withholding Treatment
1
2021
112
0.190
Why?
Microarray Analysis
2
2018
96
0.190
Why?
Models, Organizational
1
2020
45
0.190
Why?
National Institutes of Health (U.S.)
1
2021
122
0.190
Why?
Pregnancy Complications
2
2018
337
0.190
Why?
Neoplasm Metastasis
4
2013
1056
0.190
Why?
Granulocyte Colony-Stimulating Factor
1
2001
165
0.190
Why?
Neoplasm Invasiveness
5
2015
552
0.190
Why?
NF-kappa B p50 Subunit
1
2020
41
0.190
Why?
Echo-Planar Imaging
4
2017
52
0.180
Why?
Neoplasms, Germ Cell and Embryonal
2
2018
47
0.180
Why?
Water
3
2012
277
0.180
Why?
Chromosomes, Human, Pair 12
2
2019
65
0.180
Why?
Proto-Oncogene Proteins c-bcl-2
2
2000
189
0.180
Why?
Gain of Function Mutation
1
2019
13
0.180
Why?
Karyotyping
7
2000
250
0.180
Why?
Poly (ADP-Ribose) Polymerase-1
1
2019
24
0.180
Why?
Trastuzumab
3
2020
68
0.180
Why?
Survivorship
1
2020
18
0.180
Why?
Gene Amplification
5
2008
131
0.180
Why?
Fanconi Anemia Complementation Group C Protein
1
2019
4
0.180
Why?
Image Enhancement
4
2020
563
0.180
Why?
Health Occupations
1
2019
4
0.180
Why?
Research Design
5
2019
594
0.180
Why?
Noncommunicable Diseases
1
2019
5
0.180
Why?
Nucleotidyltransferases
1
2019
29
0.180
Why?
Interferon Type I
2
1998
175
0.180
Why?
Treatment Outcome
10
2020
7982
0.180
Why?
Arylamine N-Acetyltransferase
1
2019
11
0.180
Why?
Algorithms
8
2017
1830
0.180
Why?
Patient Care Planning
1
2020
81
0.170
Why?
Liver
4
2013
1229
0.170
Why?
Population Groups
1
2019
41
0.170
Why?
Apoptosis Regulatory Proteins
3
2016
199
0.170
Why?
Hospitals, University
1
2020
194
0.170
Why?
Drug Hypersensitivity
1
2019
37
0.170
Why?
Radiographic Image Enhancement
2
2012
463
0.170
Why?
Chromosomes, Human, Pair 16
5
2013
79
0.170
Why?
Neoplastic Stem Cells
2
2018
143
0.170
Why?
Pneumonia
1
2001
179
0.170
Why?
High Mobility Group Proteins
2
2016
26
0.170
Why?
Exercise
2
2023
315
0.170
Why?
Interdisciplinary Studies
1
2019
20
0.170
Why?
Sulfonamides
2
2019
300
0.170
Why?
DNA Replication
1
2019
164
0.170
Why?
Antibiotics, Antineoplastic
1
2019
114
0.170
Why?
Research Personnel
1
2019
67
0.170
Why?
Estrogen Replacement Therapy
3
2013
45
0.170
Why?
Neoplastic Syndromes, Hereditary
1
2018
18
0.170
Why?
Health Behavior
3
2010
183
0.170
Why?
Inheritance Patterns
1
2019
48
0.170
Why?
Pandemics
2
2023
737
0.170
Why?
Cell Survival
3
2019
971
0.170
Why?
Time-to-Treatment
1
2020
98
0.170
Why?
Protein Binding
4
2016
1462
0.170
Why?
RNA Interference
4
2015
370
0.160
Why?
PTEN Phosphohydrolase
2
2014
128
0.160
Why?
Gene Dosage
5
2011
207
0.160
Why?
Azacitidine
3
2009
137
0.160
Why?
Homologous Recombination
1
2018
51
0.160
Why?
Longitudinal Studies
5
2023
1019
0.160
Why?
Image Interpretation, Computer-Assisted
4
2017
663
0.160
Why?
Cancer Survivors
1
2020
85
0.160
Why?
Europe
5
2021
309
0.160
Why?
Oxidative Stress
2
2019
448
0.160
Why?
Time Factors
12
2015
5215
0.160
Why?
Continuity of Patient Care
1
2020
169
0.160
Why?
Occupations
1
2017
26
0.160
Why?
RNA, Neoplasm
1
2018
87
0.160
Why?
Haptoglobins
1
2017
9
0.160
Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
199
0.160
Why?
Radiotherapy, Adjuvant
2
2017
292
0.150
Why?
Patient Preference
1
2018
105
0.150
Why?
Cell Movement
2
2019
762
0.150
Why?
Adenomatous Polyposis Coli
2
2012
39
0.150
Why?
Cell Line
7
2016
2476
0.150
Why?
Ribosomal Protein S6 Kinases, 90-kDa
1
2017
9
0.150
Why?
Combined Modality Therapy
5
2023
1686
0.150
Why?
Human Genome Project
1
1997
19
0.150
Why?
3' Untranslated Regions
3
2019
92
0.150
Why?
Asthma
2
2019
955
0.150
Why?
Hydroxamic Acids
2
2009
49
0.150
Why?
Ovary
1
2019
258
0.150
Why?
Genetic Markers
5
2008
477
0.150
Why?
Lymphatic Metastasis
6
2018
486
0.150
Why?
Carboplatin
2
2016
286
0.150
Why?
Barbados
2
2018
7
0.150
Why?
Medical Order Entry Systems
1
2017
25
0.150
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2018
168
0.150
Why?
Communication
2
2018
440
0.150
Why?
Cystadenocarcinoma, Serous
2
2016
45
0.150
Why?
DNA Glycosylases
2
2014
24
0.150
Why?
AMP-Activated Protein Kinases
1
2017
64
0.150
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
1995
375
0.150
Why?
Sequence Analysis, RNA
1
2018
218
0.150
Why?
Maternal Exposure
1
2017
57
0.150
Why?
Immunoblastic Lymphadenopathy
1
1996
5
0.150
Why?
Polycomb Repressive Complex 2
2
2014
30
0.150
Why?
Gene-Environment Interaction
1
2018
103
0.150
Why?
Chromosomes, Human, Pair 3
1
2016
54
0.140
Why?
Placenta Growth Factor
1
2017
70
0.140
Why?
Body Weights and Measures
2
2021
27
0.140
Why?
Patient-Centered Care
1
2019
203
0.140
Why?
Human Migration
1
2016
25
0.140
Why?
Practice Guidelines as Topic
3
2019
1037
0.140
Why?
Ribonuclease III
1
2016
14
0.140
Why?
Lymphoma, Large B-Cell, Diffuse
1
1998
151
0.140
Why?
Chromosomes, Human, Pair 19
1
2016
59
0.140
Why?
Education, Medical, Undergraduate
1
2019
160
0.140
Why?
Decision Support Systems, Clinical
1
2017
103
0.140
Why?
Homeodomain Proteins
1
2020
538
0.140
Why?
Carcinoma, Non-Small-Cell Lung
5
2008
1075
0.140
Why?
Decanoic Acids
1
2016
11
0.140
Why?
Interleukin-11
2
2013
20
0.140
Why?
Glycolysis
1
2017
129
0.140
Why?
Point-of-Care Systems
1
2017
141
0.140
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2017
92
0.140
Why?
Vidarabine
1
1996
141
0.140
Why?
Cell Transformation, Neoplastic
2
1998
427
0.140
Why?
Air Pollution
1
2017
68
0.140
Why?
Quality of Life
2
2021
1587
0.140
Why?
Leuprolide
1
2016
30
0.140
Why?
Placenta
1
2017
176
0.140
Why?
Carmustine
1
2016
70
0.140
Why?
Codon, Terminator
1
2015
21
0.140
Why?
Leukemia, Radiation-Induced
1
2015
14
0.140
Why?
Internal-External Control
1
2016
44
0.140
Why?
Information Management
1
2015
7
0.140
Why?
Polyesters
1
2016
41
0.140
Why?
Cell Nucleus
2
2021
581
0.140
Why?
Gene Flow
1
2016
88
0.140
Why?
Carcinosarcoma
1
2016
20
0.140
Why?
Drug Prescriptions
1
2017
141
0.140
Why?
Adaptor Proteins, Signal Transducing
3
2015
306
0.140
Why?
Cloning, Molecular
3
1995
646
0.140
Why?
Epithelial Cells
3
2017
670
0.140
Why?
Internal Medicine
2
2009
349
0.140
Why?
Religion
1
2016
87
0.130
Why?
Nitriles
1
2016
149
0.130
Why?
Genes, Mitochondrial
1
2015
9
0.130
Why?
Incidence
8
2015
1578
0.130
Why?
Guideline Adherence
1
2017
224
0.130
Why?
Adenocarcinoma, Clear Cell
1
2016
62
0.130
Why?
Craniotomy
1
2016
88
0.130
Why?
Lymph Nodes
2
2009
533
0.130
Why?
Triazoles
1
2016
96
0.130
Why?
Transcription, Genetic
3
2009
1138
0.130
Why?
Health Services Needs and Demand
2
2013
102
0.130
Why?
Sensitivity and Specificity
8
2014
1991
0.130
Why?
Lymphoid Enhancer-Binding Factor 1
1
2015
13
0.130
Why?
Registries
6
2021
703
0.130
Why?
Insulin-Like Growth Factor II
2
2013
33
0.130
Why?
Vitamin D
1
2017
261
0.130
Why?
Cyclin-Dependent Kinases
1
1995
43
0.130
Why?
Benzimidazoles
1
2016
140
0.130
Why?
Telephone
3
2020
32
0.130
Why?
Health Surveys
2
2021
239
0.130
Why?
Pilot Projects
5
2022
840
0.130
Why?
Vimentin
2
2012
44
0.130
Why?
Enhancer Elements, Genetic
3
2016
269
0.130
Why?
Cadherins
2
2018
153
0.130
Why?
Immunoenzyme Techniques
2
2012
303
0.130
Why?
Wnt Proteins
2
2018
124
0.130
Why?
Terminology as Topic
2
2015
217
0.130
Why?
Insulin Receptor Substrate Proteins
2
2012
55
0.130
Why?
Bone Marrow
2
1995
435
0.130
Why?
Chromosome Banding
3
2004
74
0.130
Why?
Health Literacy
1
2016
69
0.130
Why?
Leukemia, Myeloid, Acute
2
2004
763
0.130
Why?
Interprofessional Relations
2
2019
121
0.130
Why?
Genes, Reporter
2
2015
271
0.120
Why?
Social Isolation
2
2021
67
0.120
Why?
Mammary Glands, Human
1
2014
22
0.120
Why?
Cytoskeleton
2
2013
193
0.120
Why?
Laboratories
2
2013
43
0.120
Why?
Biomarkers
4
2017
1722
0.120
Why?
ROC Curve
7
2012
752
0.120
Why?
Curriculum
1
2019
542
0.120
Why?
Neoplasms, Multiple Primary
1
2014
100
0.120
Why?
Health Care Reform
1
2015
90
0.120
Why?
Oncogenes
1
2014
88
0.120
Why?
Students, Medical
1
2019
385
0.120
Why?
Predictive Value of Tests
7
2020
1672
0.120
Why?
Transcription Factor 7-Like 1 Protein
1
2013
8
0.120
Why?
Primary Prevention
2
2014
85
0.120
Why?
Qualitative Research
1
2014
256
0.120
Why?
Pregnancy Complications, Neoplastic
1
2013
28
0.110
Why?
Chemoradiotherapy
1
2016
301
0.110
Why?
Phytotherapy
1
2014
133
0.110
Why?
Nerve Tissue Proteins
2
2010
504
0.110
Why?
Tissue Array Analysis
1
2013
124
0.110
Why?
Epidemiologic Studies
1
2013
17
0.110
Why?
Breast Self-Examination
1
2013
3
0.110
Why?
Communications Media
1
2013
2
0.110
Why?
Feasibility Studies
2
2013
751
0.110
Why?
Computer Simulation
4
2018
1079
0.110
Why?
Alcohol Oxidoreductases
1
2013
17
0.110
Why?
Practice Patterns, Physicians'
1
2018
584
0.110
Why?
Smoke
1
2013
27
0.110
Why?
Inhalation Exposure
1
2013
28
0.110
Why?
Rescue Work
1
2012
7
0.110
Why?
Informed Consent
2
2014
266
0.110
Why?
Relief Work
1
2012
7
0.110
Why?
Drug Administration Schedule
3
2010
915
0.110
Why?
Epithelium
2
2013
319
0.110
Why?
Earthquakes
1
2012
12
0.110
Why?
Mass Casualty Incidents
1
2012
12
0.110
Why?
Leukemia, Erythroblastic, Acute
1
1992
29
0.110
Why?
Sequence Homology, Amino Acid
3
2006
416
0.110
Why?
Cooperative Behavior
2
2012
176
0.110
Why?
Disasters
1
2012
20
0.110
Why?
Tanzania
1
2012
45
0.110
Why?
Altruism
1
2012
35
0.110
Why?
Radiosurgery
1
2016
272
0.110
Why?
History, 20th Century
1
2014
312
0.110
Why?
Wnt Signaling Pathway
1
2013
94
0.110
Why?
Drug Discovery
2
2015
103
0.110
Why?
Carcinoma, Small Cell
1
1993
134
0.110
Why?
Carcinoma in Situ
1
2012
53
0.110
Why?
Class I Phosphatidylinositol 3-Kinases
3
2018
56
0.110
Why?
Hypoxia
1
2017
642
0.110
Why?
Cytoplasm
1
2013
282
0.110
Why?
Chromatin Immunoprecipitation
2
2010
135
0.110
Why?
Waist Circumference
1
2012
20
0.110
Why?
Patient Acceptance of Health Care
1
2014
238
0.100
Why?
Cancer Care Facilities
2
2015
28
0.100
Why?
Quality Assurance, Health Care
1
2013
219
0.100
Why?
Kisspeptins
1
2011
4
0.100
Why?
Protein Kinase Inhibitors
3
2011
589
0.100
Why?
DNA, Complementary
3
2007
394
0.100
Why?
Observer Variation
1
2013
602
0.100
Why?
Mastectomy, Segmental
2
2017
93
0.100
Why?
Dose-Response Relationship, Drug
4
2012
1960
0.100
Why?
Models, Theoretical
1
2014
482
0.100
Why?
Mutation Rate
1
2012
48
0.100
Why?
Alcohol Drinking
1
2014
267
0.100
Why?
Organoplatinum Compounds
1
2011
94
0.100
Why?
Microsatellite Instability
1
2011
43
0.100
Why?
Extracellular Matrix
1
2013
235
0.100
Why?
Polychondritis, Relapsing
1
2011
5
0.100
Why?
Bayes Theorem
3
2022
361
0.100
Why?
DNA, Recombinant
1
2011
67
0.100
Why?
Telomerase
1
2011
55
0.100
Why?
Consensus Sequence
1
2011
64
0.100
Why?
Codon, Nonsense
1
2011
42
0.100
Why?
Lymphocytes
4
2005
465
0.100
Why?
Cytochrome P-450 CYP2D6 Inhibitors
1
2011
5
0.100
Why?
Deafness
1
2011
47
0.100
Why?
Pericardial Effusion
1
1991
20
0.100
Why?
Stomach Neoplasms
2
2011
266
0.100
Why?
Thyroid Neoplasms
1
2016
408
0.100
Why?
Pleural Effusion
1
1991
46
0.100
Why?
Internet
1
2013
312
0.100
Why?
Health Promotion
1
2013
160
0.100
Why?
Contraceptives, Oral
2
2020
46
0.100
Why?
Arthritis
1
2011
46
0.100
Why?
Regulatory Elements, Transcriptional
1
2011
45
0.100
Why?
Parents
2
2012
272
0.100
Why?
Mice, Nude
4
2019
789
0.100
Why?
Radiotherapy
2
2011
328
0.100
Why?
Poverty
2
2013
173
0.100
Why?
Ataxin-7
1
2010
5
0.100
Why?
Lung Diseases
1
2013
263
0.100
Why?
HIV Infections
1
2019
773
0.100
Why?
Serine Endopeptidases
1
2011
145
0.090
Why?
Chromosome Breakpoints
1
2010
15
0.090
Why?
Heredity
1
2010
19
0.090
Why?
Protein Isoforms
1
2011
272
0.090
Why?
Minors
1
2010
15
0.090
Why?
Rad51 Recombinase
2
2009
80
0.090
Why?
Histones
2
2013
311
0.090
Why?
Interinstitutional Relations
1
2010
28
0.090
Why?
Repressor Proteins
2
2011
405
0.090
Why?
Diabetes Complications
1
2012
207
0.090
Why?
Receptor Protein-Tyrosine Kinases
1
2011
153
0.090
Why?
Hodgkin Disease
1
2011
177
0.090
Why?
SEER Program
2
2014
190
0.090
Why?
Blotting, Southern
3
1995
129
0.090
Why?
Academic Medical Centers
1
2012
378
0.090
Why?
Taxoids
3
2020
129
0.090
Why?
Models, Genetic
4
2018
929
0.090
Why?
Senegal
1
2009
4
0.090
Why?
Hypersensitivity
1
2011
154
0.090
Why?
Restriction Mapping
3
1995
157
0.090
Why?
Aromatase Inhibitors
1
2009
28
0.090
Why?
Emergency Medical Services
1
2012
209
0.090
Why?
Fatal Outcome
3
2001
295
0.090
Why?
RNA Splice Sites
2
2016
53
0.090
Why?
Amino Acid Sequence
3
2006
2065
0.090
Why?
Health Services Research
1
2010
136
0.090
Why?
Transfection
1
2011
898
0.090
Why?
Adult Children
1
2009
12
0.090
Why?
Genes, p53
2
2001
109
0.090
Why?
Somatomedins
1
2009
28
0.080
Why?
DNA (Cytosine-5-)-Methyltransferases
1
2009
57
0.080
Why?
Insulin-Like Growth Factor Binding Proteins
1
2009
22
0.080
Why?
Cluster Analysis
4
2013
369
0.080
Why?
Acute Disease
3
2004
827
0.080
Why?
Online Systems
1
2008
24
0.080
Why?
Skin
1
2012
554
0.080
Why?
Esophageal Neoplasms
1
2011
322
0.080
Why?
Models, Statistical
2
2018
575
0.080
Why?
Urban Health
2
2011
55
0.080
Why?
MAP Kinase Kinase Kinase 1
1
2008
10
0.080
Why?
Recurrence
4
2018
1139
0.080
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2008
5
0.080
Why?
Insulin-Like Growth Factor Binding Protein 5
1
2008
7
0.080
Why?
Confidence Intervals
3
2013
229
0.080
Why?
DNA Repair Enzymes
3
2015
52
0.080
Why?
International Classification of Diseases
1
2008
69
0.080
Why?
Chromosomes, Human, Pair 8
3
2019
85
0.080
Why?
Phantoms, Imaging
1
2010
429
0.080
Why?
Anticarcinogenic Agents
2
2000
70
0.080
Why?
Pyrazines
2
2000
92
0.080
Why?
Lysine
2
2020
147
0.080
Why?
Health Status Indicators
1
2008
105
0.080
Why?
Dinucleotide Repeats
1
2007
13
0.080
Why?
Child
8
2013
6928
0.080
Why?
Inflammation
1
2013
926
0.080
Why?
Medically Uninsured
1
2007
58
0.080
Why?
Receptors, Glucocorticoid
1
2008
120
0.070
Why?
Probability
2
2005
354
0.070
Why?
Hot Temperature
2
2005
206
0.070
Why?
Chromosomes, Human, Pair 2
3
2016
85
0.070
Why?
User-Computer Interface
1
2008
185
0.070
Why?
Estrogens
1
2008
200
0.070
Why?
Methylation
2
2013
251
0.070
Why?
Diabetes Mellitus
1
2014
805
0.070
Why?
Datasets as Topic
2
2019
71
0.070
Why?
Urban Population
2
2020
214
0.070
Why?
T-Lymphocytes
1
2013
1200
0.070
Why?
Chromatin
3
2013
384
0.070
Why?
Research Support as Topic
2
2019
80
0.070
Why?
Geography
2
2018
223
0.070
Why?
Genes, APC
1
2006
26
0.070
Why?
Abortion, Therapeutic
1
2006
11
0.070
Why?
Genes, Neoplasm
1
2006
37
0.070
Why?
Subtraction Technique
1
2006
132
0.070
Why?
Neovascularization, Physiologic
1
2007
140
0.070
Why?
Carcinogenesis
2
2018
195
0.070
Why?
Leukemia, Promyelocytic, Acute
1
2006
49
0.070
Why?
Mammary Neoplasms, Experimental
1
2007
124
0.070
Why?
Gene Expression Regulation
2
2010
1928
0.070
Why?
Breast Density
2
2017
31
0.070
Why?
Child Development
1
2007
163
0.070
Why?
Paraffin Embedding
1
2005
78
0.070
Why?
Microwaves
1
2005
34
0.070
Why?
Conserved Sequence
1
2006
210
0.070
Why?
Abortion, Spontaneous
1
2006
66
0.070
Why?
Statistics as Topic
1
2006
238
0.070
Why?
Postpartum Period
2
2018
135
0.070
Why?
Tissue Culture Techniques
1
2005
80
0.070
Why?
Imaging, Three-Dimensional
1
2009
581
0.070
Why?
Structure-Activity Relationship
1
2006
408
0.060
Why?
Electrophoresis, Gel, Pulsed-Field
3
1995
20
0.060
Why?
NAD(P)H Dehydrogenase (Quinone)
1
2004
8
0.060
Why?
Discriminant Analysis
2
2007
66
0.060
Why?
Membrane Proteins
1
2011
1201
0.060
Why?
Choice Behavior
1
2006
160
0.060
Why?
Hormone Replacement Therapy
1
2005
77
0.060
Why?
Ethanol
2
2017
249
0.060
Why?
Attitude to Health
1
2006
220
0.060
Why?
Culture
1
2005
53
0.060
Why?
Disease Susceptibility
2
2018
195
0.060
Why?
Smoking
2
2019
609
0.060
Why?
Adipose Tissue
1
2006
241
0.060
Why?
Down-Regulation
3
2015
508
0.060
Why?
Stress, Psychological
1
2007
314
0.060
Why?
Software
3
2017
653
0.060
Why?
Protein Structure, Tertiary
1
2006
738
0.060
Why?
MutL Protein Homolog 1
2
2015
33
0.060
Why?
MutS Homolog 2 Protein
2
2015
30
0.060
Why?
North America
3
2011
180
0.060
Why?
Enhancer of Zeste Homolog 2 Protein
2
2014
35
0.060
Why?
Peptide Synthases
1
2003
12
0.060
Why?
Raloxifene Hydrochloride
1
2023
10
0.060
Why?
Vincristine
2
1996
111
0.060
Why?
National Cancer Institute (U.S.)
2
2014
70
0.060
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
2
2018
151
0.060
Why?
Antigens, CD
2
2018
459
0.060
Why?
Personal Satisfaction
1
2023
62
0.060
Why?
Prednisone
2
1996
258
0.060
Why?
Contraceptives, Oral, Hormonal
1
2002
18
0.060
Why?
International Cooperation
2
2014
127
0.060
Why?
Genetic Linkage
2
2004
623
0.050
Why?
Metabolomics
1
2023
68
0.050
Why?
DNA Primers
6
2007
545
0.050
Why?
Hormones
1
2023
141
0.050
Why?
Counseling
1
2023
145
0.050
Why?
Diabetes Mellitus, Type 2
1
2012
1374
0.050
Why?
Cyclin D1
1
2002
83
0.050
Why?
Child, Preschool
4
2010
3612
0.050
Why?
International Agencies
2
2014
34
0.050
Why?
Genes, Dominant
2
2004
117
0.050
Why?
Data Accuracy
1
2021
31
0.050
Why?
Tertiary Care Centers
1
2021
94
0.050
Why?
Sendai virus
1
2021
8
0.050
Why?
Respirovirus Infections
1
2021
12
0.050
Why?
Retinoblastoma Protein
1
2001
66
0.050
Why?
Transcription Factor RelA
1
2021
50
0.050
Why?
Multiple Myeloma
1
2005
307
0.050
Why?
DNA Damage
2
2019
366
0.050
Why?
Canada
2
2015
202
0.050
Why?
Primary Cell Culture
1
2021
72
0.050
Why?
Protective Factors
1
2020
22
0.050
Why?
Gene Knockout Techniques
1
2021
77
0.050
Why?
Acid Anhydride Hydrolases
2
2011
13
0.050
Why?
Bridged-Ring Compounds
1
2020
13
0.050
Why?
Ferredoxin-NADP Reductase
1
2020
15
0.050
Why?
Phylogeny
2
2016
1137
0.050
Why?
Ubiquitination
1
2020
67
0.050
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2020
26
0.050
Why?
Serine
1
2020
99
0.050
Why?
Mice, Inbred C3H
1
2020
371
0.050
Why?
Patient Reported Outcome Measures
1
2021
164
0.050
Why?
Genetic Research
2
1997
17
0.050
Why?
Minichromosome Maintenance Complex Component 2
1
2019
2
0.050
Why?
Protein Domains
1
2020
128
0.050
Why?
Melanoma
2
1995
459
0.050
Why?
Patient Satisfaction
1
2023
454
0.050
Why?
Evolution, Molecular
1
2006
813
0.050
Why?
Genotyping Techniques
1
2020
68
0.040
Why?
Zinc Finger E-box-Binding Homeobox 1
1
2019
4
0.040
Why?
Fanconi Anemia
1
2019
7
0.040
Why?
Propensity Score
1
2020
136
0.040
Why?
Computers
1
2000
112
0.040
Why?
Glutathione
2
2000
104
0.040
Why?
Africa, Northern
1
2019
5
0.040
Why?
Glutathione Transferase
2
2000
111
0.040
Why?
Bronchi
1
2001
229
0.040
Why?
Biophysical Phenomena
1
2000
120
0.040
Why?
Middle East
1
2019
17
0.040
Why?
Interferon-alpha
2
1998
234
0.040
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2019
17
0.040
Why?
Biophysics
1
2000
152
0.040
Why?
Colonic Polyps
1
2000
127
0.040
Why?
Academies and Institutes
1
2019
31
0.040
Why?
Chi-Square Distribution
2
2015
364
0.040
Why?
HIV
1
2019
46
0.040
Why?
Menopause
1
2019
71
0.040
Why?
Data Mining
1
2019
42
0.040
Why?
Haploinsufficiency
1
2019
62
0.040
Why?
Kruppel-Like Transcription Factors
1
2019
96
0.040
Why?
APOBEC Deaminases
1
2018
5
0.040
Why?
Antineoplastic Agents, Alkylating
1
2019
138
0.040
Why?
Antiphospholipid Syndrome
1
1999
20
0.040
Why?
China
1
2019
228
0.040
Why?
Population Health
1
2019
33
0.040
Why?
Palpation
1
2018
18
0.040
Why?
Plasma Exchange
1
1999
29
0.040
Why?
O(6)-Methylguanine-DNA Methyltransferase
1
1999
118
0.040
Why?
Codon
1
1999
124
0.040
Why?
Pregnancy Trimester, Third
1
2018
70
0.040
Why?
Cells, Cultured
3
2007
2839
0.040
Why?
Genomic Library
2
1995
33
0.040
Why?
Regression Analysis
1
2000
596
0.040
Why?
Neoplasms, Hormone-Dependent
1
1998
40
0.040
Why?
Transplantation, Heterologous
1
2019
363
0.040
Why?
Protein Processing, Post-Translational
1
2020
371
0.040
Why?
Image-Guided Biopsy
1
2018
66
0.040
Why?
Penetrance
1
2018
44
0.040
Why?
Biological Transport
2
2010
396
0.040
Why?
Receptors, Notch
1
2018
123
0.040
Why?
Models, Biological
2
2008
1752
0.040
Why?
Neoplasm Transplantation
1
2018
392
0.040
Why?
Ultrasonography, Mammary
1
2018
82
0.040
Why?
Cell Hypoxia
1
2018
165
0.040
Why?
Medicare
1
2021
408
0.040
Why?
Diagnosis, Differential
3
2009
1564
0.040
Why?
American Cancer Society
1
1997
13
0.040
Why?
Asia
1
2017
95
0.040
Why?
Genes, bcl-2
1
1997
16
0.040
Why?
Physical Examination
1
2018
149
0.040
Why?
Cytochrome P-450 Enzyme System
1
1998
79
0.040
Why?
Mixed Function Oxygenases
1
1998
68
0.040
Why?
Fibroblasts
1
2020
731
0.040
Why?
Autoantibodies
1
1999
268
0.040
Why?
Glycoproteins
1
1999
234
0.040
Why?
bcl-X Protein
1
1997
52
0.040
Why?
Purines
1
1997
91
0.040
Why?
Immunity, Innate
1
2021
410
0.040
Why?
Telomere-Binding Proteins
1
2017
14
0.040
Why?
Cell Differentiation
2
2014
1471
0.040
Why?
Drug Labeling
1
2017
41
0.040
Why?
Patient Compliance
1
2018
228
0.040
Why?
DNA
2
2001
1295
0.040
Why?
Cyclooxygenase 2 Inhibitors
1
2017
33
0.040
Why?
HL-60 Cells
1
1997
20
0.040
Why?
Nucleic Acid Hybridization
1
1997
245
0.040
Why?
Comorbidity
1
2021
945
0.040
Why?
Mice, Inbred BALB C
1
2019
1059
0.040
Why?
Meta-Analysis as Topic
1
2017
87
0.040
Why?
Organizational Policy
1
1997
55
0.040
Why?
Educational Measurement
1
2019
226
0.040
Why?
Fetal Blood
1
2017
90
0.040
Why?
Health Care Costs
1
2019
238
0.040
Why?
Federal Government
1
1996
29
0.040
Why?
Cytokines
1
2021
781
0.040
Why?
DNA, Intergenic
1
2016
25
0.040
Why?
Empirical Research
1
1996
19
0.040
Why?
Reproducibility of Results
3
2009
2704
0.040
Why?
Neuroblastoma
1
2020
375
0.040
Why?
Chemoprevention
1
2017
92
0.040
Why?
Signal-To-Noise Ratio
1
2017
96
0.040
Why?
Tumor Burden
1
2018
290
0.040
Why?
Chromosomes, Human, Pair 11
1
2016
106
0.040
Why?
Autoimmune Diseases
1
1999
241
0.040
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
1998
173
0.040
Why?
Cyclophilins
1
2016
8
0.040
Why?
Italy
1
2016
106
0.040
Why?
tRNA Methyltransferases
1
2016
12
0.040
Why?
Mutagenesis, Insertional
1
1997
111
0.040
Why?
Decision Making
2
2016
643
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p15
1
1996
24
0.030
Why?
Sexism
1
2016
51
0.030
Why?
Pregnancy Outcome
1
2017
247
0.030
Why?
Genetic Diseases, Inborn
1
1996
101
0.030
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2016
72
0.030
Why?
Organizations, Nonprofit
1
2015
8
0.030
Why?
Aspirin
1
2017
155
0.030
Why?
Income
1
2016
76
0.030
Why?
Hematopoietic Stem Cells
1
1998
292
0.030
Why?
Affect
1
2018
386
0.030
Why?
Cisplatin
2
2008
612
0.030
Why?
Mismatch Repair Endonuclease PMS2
1
2015
23
0.030
Why?
Critical Care
1
1999
371
0.030
Why?
Cosmids
1
1995
22
0.030
Why?
Educational Status
1
2016
190
0.030
Why?
Mental Disorders
1
2019
371
0.030
Why?
Interphase
1
1995
34
0.030
Why?
Functional Laterality
2
2006
201
0.030
Why?
Neoplasms, Experimental
2
2013
269
0.030
Why?
Cyclin-Dependent Kinase 4
1
1995
28
0.030
Why?
Genes, Retinoblastoma
1
1995
22
0.030
Why?
Information Dissemination
1
2015
103
0.030
Why?
Nucleotides
1
2015
95
0.030
Why?
Adenosine Triphosphatases
1
2015
153
0.030
Why?
Reference Standards
2
2010
159
0.030
Why?
Cetuximab
1
2015
113
0.030
Why?
Methotrexate
2
1997
249
0.030
Why?
Pain Management
1
2015
126
0.030
Why?
Public-Private Sector Partnerships
1
2014
5
0.030
Why?
Bone Marrow Cells
1
1995
253
0.030
Why?
Social Support
1
2016
193
0.030
Why?
Government Agencies
1
2014
10
0.030
Why?
Foundations
1
2014
25
0.030
Why?
Monocytes
1
1995
216
0.030
Why?
Cell Membrane
2
2007
666
0.030
Why?
Survivors
1
2015
227
0.030
Why?
Disease Models, Animal
1
2020
2243
0.030
Why?
Dietary Supplements
1
2014
128
0.030
Why?
False Negative Reactions
1
2013
63
0.030
Why?
Cognition
1
2018
571
0.030
Why?
Ethics, Research
1
2014
52
0.030
Why?
Magnetic Resonance Imaging, Interventional
1
2013
36
0.030
Why?
Endothelium
1
2013
59
0.030
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2013
21
0.030
Why?
Telomere
1
1994
108
0.030
Why?
Receptor, IGF Type 1
1
2013
44
0.030
Why?
Claudins
1
2013
33
0.030
Why?
Protein Stability
1
2013
99
0.030
Why?
Biomarkers, Pharmacological
1
2013
22
0.030
Why?
Caloric Restriction
1
2013
14
0.030
Why?
Suppression, Genetic
1
2013
30
0.030
Why?
Ultrasonography, Interventional
1
2013
121
0.030
Why?
Incidental Findings
1
2013
95
0.030
Why?
Immunoblotting
1
2013
268
0.030
Why?
Translating
1
2012
18
0.030
Why?
Haiti
1
2012
21
0.030
Why?
Respiratory Function Tests
1
2013
136
0.030
Why?
Urinary Bladder
1
1995
245
0.030
Why?
Oxidants
1
2013
86
0.030
Why?
Capillary Permeability
1
2013
130
0.030
Why?
Volunteers
1
2012
19
0.030
Why?
Nutritional Status
1
2013
83
0.030
Why?
Environmental Monitoring
1
2013
71
0.030
Why?
Oligodendroglioma
1
1992
45
0.030
Why?
Equipment and Supplies
1
2012
30
0.030
Why?
Enzyme Inhibitors
1
1996
639
0.030
Why?
Microscopy, Confocal
1
2013
268
0.030
Why?
Risk Management
1
2012
43
0.030
Why?
Insulin-Like Growth Factor I
1
2013
114
0.030
Why?
Drug Interactions
1
2013
248
0.030
Why?
Evaluation Studies as Topic
1
2012
274
0.030
Why?
Gadolinium DTPA
1
2013
261
0.030
Why?
Astrocytoma
1
1992
82
0.030
Why?
Maximum Tolerated Dose
1
2013
270
0.030
Why?
Rural Population
1
2013
136
0.030
Why?
History, 21st Century
1
2013
175
0.030
Why?
Xeroderma Pigmentosum
1
2011
9
0.030
Why?
Cell Adhesion
1
2013
422
0.030
Why?
Endonucleases
1
2011
21
0.030
Why?
Carcinoembryonic Antigen
1
2011
41
0.030
Why?
Sex Factors
1
2015
1053
0.030
Why?
Fats
1
2011
12
0.030
Why?
Sirolimus
1
2013
170
0.030
Why?
Air Pollutants
1
2013
78
0.030
Why?
Guidelines as Topic
1
2013
162
0.030
Why?
Anthracyclines
1
2011
37
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2013
276
0.030
Why?
Positive Regulatory Domain I-Binding Factor 1
1
2011
13
0.030
Why?
High-Temperature Requirement A Serine Peptidase 1
1
2011
1
0.030
Why?
Receptors, Steroid
1
2011
42
0.030
Why?
Rural Health
1
2011
20
0.030
Why?
Antioxidants
1
2013
223
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2012
262
0.030
Why?
Matched-Pair Analysis
2
2002
43
0.030
Why?
Multicenter Studies as Topic
1
2011
159
0.030
Why?
HapMap Project
1
2011
47
0.020
Why?
Receptors, Growth Factor
1
2011
52
0.020
Why?
Mesothelioma
1
1994
311
0.020
Why?
HEK293 Cells
1
2013
617
0.020
Why?
Dose-Response Relationship, Radiation
1
2011
188
0.020
Why?
Proteins
1
1996
777
0.020
Why?
STAT3 Transcription Factor
1
2011
78
0.020
Why?
Proto-Oncogene Proteins c-akt
1
2012
323
0.020
Why?
Sodium-Bicarbonate Symporters
1
2010
7
0.020
Why?
Gene Silencing
1
2011
173
0.020
Why?
Ascites
1
1991
56
0.020
Why?
Hepatocyte Growth Factor
1
2011
84
0.020
Why?
Species Specificity
2
2007
678
0.020
Why?
Palliative Care
1
2013
257
0.020
Why?
Principal Component Analysis
1
2011
155
0.020
Why?
Stem Cells
1
2013
358
0.020
Why?
Perception
1
2012
168
0.020
Why?
Oils
1
2010
6
0.020
Why?
Vesicular Transport Proteins
1
2010
63
0.020
Why?
Analysis of Variance
1
1992
911
0.020
Why?
Chromosomes, Human, Pair 22
1
1990
44
0.020
Why?
Injections
1
2010
108
0.020
Why?
Chromosomes, Human, Pair 14
1
1990
49
0.020
Why?
Gene Regulatory Networks
1
2013
297
0.020
Why?
Patient Care Team
1
2012
280
0.020
Why?
Thigh
1
1990
38
0.020
Why?
Phosphorylation
1
2012
1106
0.020
Why?
Glucose
1
2013
638
0.020
Why?
Bleomycin
1
1990
98
0.020
Why?
NF-E2-Related Factor 2
1
2010
41
0.020
Why?
MRE11 Homologue Protein
1
2009
2
0.020
Why?
Leucovorin
1
1990
218
0.020
Why?
Endodeoxyribonucleases
1
2009
11
0.020
Why?
Fanconi Anemia Complementation Group Proteins
1
2009
8
0.020
Why?
Arthralgia
1
2009
36
0.020
Why?
Proto-Oncogene Proteins c-met
1
2011
199
0.020
Why?
Piperazines
1
2011
272
0.020
Why?
Radiography
1
2011
808
0.020
Why?
Indoles
1
2011
318
0.020
Why?
Angiopoietins
1
2009
6
0.020
Why?
Translocation, Genetic
1
1990
265
0.020
Why?
Cytarabine
1
1990
218
0.020
Why?
Family Practice
1
2009
84
0.020
Why?
Cause of Death
1
2010
277
0.020
Why?
RNA Helicases
1
2009
35
0.020
Why?
Organ Specificity
1
2010
263
0.020
Why?
Soft Tissue Neoplasms
1
1990
126
0.020
Why?
Monocarboxylic Acid Transporters
1
2009
79
0.020
Why?
Thiones
2
2000
10
0.020
Why?
Sequence Homology, Nucleic Acid
2
2001
173
0.020
Why?
Erlotinib Hydrochloride
1
2008
90
0.020
Why?
Symporters
1
2009
107
0.020
Why?
Carcinoma, Medullary
1
2008
11
0.020
Why?
Chromosomes, Human, Pair 18
1
2008
42
0.020
Why?
Thiophenes
2
2000
48
0.020
Why?
Ribosomal Proteins
1
2008
43
0.020
Why?
Hawaii
1
2007
26
0.020
Why?
Isoleucine
1
2007
17
0.020
Why?
Adaptation, Psychological
1
2009
158
0.020
Why?
Etoposide
1
2008
196
0.020
Why?
Diagnostic Imaging
1
2012
468
0.020
Why?
Threonine
1
2007
33
0.020
Why?
Leucine
1
2007
67
0.020
Why?
Chromosomes, Human, Pair 1
1
2008
100
0.020
Why?
Histidine
1
2007
55
0.020
Why?
Kinetics
1
2010
1513
0.020
Why?
Proline
1
2007
57
0.020
Why?
Aurora Kinase A
1
2007
9
0.020
Why?
Neurosecretory Systems
1
2007
35
0.020
Why?
Aurora Kinases
1
2007
17
0.020
Why?
Tyrosine
1
2007
133
0.020
Why?
Health Status
1
2009
360
0.020
Why?
Fractals
1
2007
42
0.020
Why?
Carcinoma, Ductal
1
2007
18
0.020
Why?
Cyclin A1
1
2006
2
0.020
Why?
Cathepsin K
1
2006
3
0.020
Why?
MSX1 Transcription Factor
1
2006
3
0.020
Why?
Carcinoma, Adenosquamous
1
2006
12
0.020
Why?
Selection, Genetic
1
2011
502
0.020
Why?
Cyclin A
1
2006
28
0.020
Why?
Cathepsins
1
2006
21
0.020
Why?
DNA Modification Methylases
1
2006
25
0.020
Why?
X-Rays
1
2007
130
0.020
Why?
Antibodies, Monoclonal
1
2013
1380
0.020
Why?
Hospitals, Public
1
2006
15
0.020
Why?
Remission Induction
1
2008
722
0.020
Why?
Aging
1
2011
693
0.020
Why?
Israel
1
2006
55
0.020
Why?
Keratin-5
1
2006
3
0.020
Why?
Keratin-6
1
2006
3
0.020
Why?
Infant
2
2007
3048
0.020
Why?
Keratins
1
2006
63
0.020
Why?
Chronic Disease
1
2009
972
0.020
Why?
Neprilysin
1
2006
42
0.020
Why?
Thionucleosides
2
1997
8
0.020
Why?
Deoxyadenosines
2
1997
23
0.020
Why?
Sample Size
1
2006
130
0.020
Why?
Residence Characteristics
1
2007
197
0.020
Why?
Health Policy
1
2007
180
0.020
Why?
Menstruation
1
2005
30
0.020
Why?
Microscopy, Fluorescence
1
2007
425
0.020
Why?
Genome
1
2008
372
0.020
Why?
CCCTC-Binding Factor
1
2004
18
0.020
Why?
NFATC Transcription Factors
1
2004
48
0.020
Why?
Phosphoproteins
1
2006
255
0.020
Why?
Endothelium, Vascular
1
2007
437
0.020
Why?
Repetitive Sequences, Nucleic Acid
2
1995
135
0.020
Why?
Body Water
1
2004
35
0.020
Why?
Chromosomes
1
2004
96
0.020
Why?
Transcription Factor AP-2
1
2004
14
0.020
Why?
Muscle, Smooth
1
2006
354
0.020
Why?
Actins
1
2006
451
0.010
Why?
Cell Division
1
2004
696
0.010
Why?
Physical Chromosome Mapping
1
2001
27
0.010
Why?
5' Untranslated Regions
1
2001
49
0.010
Why?
Blotting, Northern
1
2001
258
0.010
Why?
Open Reading Frames
1
2001
117
0.010
Why?
Scotland
1
2000
6
0.010
Why?
Rectum
1
2000
146
0.010
Why?
Radiation Injuries
1
2000
156
0.010
Why?
beta 2-Glycoprotein I
1
1999
5
0.010
Why?
Gangrene
1
1999
7
0.010
Why?
Scleroderma, Localized
1
1999
9
0.010
Why?
Hematoma, Subdural
1
1999
23
0.010
Why?
Drug Screening Assays, Antitumor
1
1999
78
0.010
Why?
Leg
1
1999
137
0.010
Why?
Cattle
1
1999
376
0.010
Why?
Fingers
1
1999
68
0.010
Why?
Medical History Taking
1
1998
80
0.010
Why?
Azaserine
1
1997
4
0.010
Why?
Cytochrome P-450 CYP3A
1
1998
43
0.010
Why?
Guanine
1
1999
208
0.010
Why?
Antimalarials
1
1997
20
0.010
Why?
Societies
1
1997
12
0.010
Why?
Reproductive Techniques, Assisted
1
1997
15
0.010
Why?
Methionine
1
1997
66
0.010
Why?
Cell Count
1
1997
197
0.010
Why?
Genetics
1
1997
24
0.010
Why?
Tumor Suppressor Protein p14ARF
1
1996
7
0.010
Why?
Polymorphism, Single-Stranded Conformational
1
1996
29
0.010
Why?
Professional Competence
1
1997
68
0.010
Why?
Ischemia
1
1999
243
0.010
Why?
Leukemia, T-Cell
1
1995
17
0.010
Why?
Leukemia, B-Cell
1
1995
23
0.010
Why?
Thrombosis
1
1999
296
0.010
Why?
Enzyme Induction
1
1995
88
0.010
Why?
Metaphase
1
1995
25
0.010
Why?
Biological Availability
1
1995
92
0.010
Why?
Ploidies
1
1995
40
0.010
Why?
Anticoagulants
1
1999
407
0.010
Why?
Genes, Overlapping
1
1994
4
0.010
Why?
Adenosine
1
1997
225
0.010
Why?
Area Under Curve
1
1995
334
0.010
Why?
Hybrid Cells
1
1994
72
0.010
Why?
Crossing Over, Genetic
1
1994
33
0.010
Why?
Cellular Senescence
1
1995
94
0.010
Why?
Gene Library
1
1994
131
0.010
Why?
Administration, Oral
1
1995
683
0.010
Why?
Immunosuppressive Agents
1
1999
977
0.010
Why?
Tetrahydrofolates
1
1993
13
0.010
Why?
Carcinoma, Transitional Cell
1
1995
164
0.010
Why?
Interferon-beta
1
1994
125
0.010
Why?
Chromosomes, Human, Pair 10
1
1992
47
0.010
Why?
Polymorphism, Restriction Fragment Length
1
1992
147
0.010
Why?
Rats
1
1997
4004
0.010
Why?
Blast Crisis
1
1990
33
0.010
Why?
Burkitt Lympho